| Entry |
|
| Name |
Dobutamine hydrochloride (JP16/USP);
Dobutrex (TN)
|
| Product |
|
| Generic |
|
| Formula |
C18H23NO3. HCl
|
| Exact mass |
337.1445
|
| Mol weight |
337.8411
|
| Structure |

     |
| Activity |
Cardiotonic
|
| Remark |
Therapeutic category: ATC code: |
| Target |
beta1-adrenergic receptor agonist [HSA: 153] [KO: K04141] |
| Pathway |
|
| Interaction |
|
| Structure map |
| beta-Adrenergic receptor agonists/antagonists |
|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
211 Cardiotonics
2119 Others
D00632 Dobutamine hydrochloride (JP16/USP)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CA Adrenergic and dopaminergic agents
C01CA07 Dobutamine
D00632 Dobutamine hydrochloride (JP16/USP)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
beta1-adrenergic receptor [HSA:153] [KO:K04141]
Dobutamine [ATC:C01CA07]
D00632 Dobutamine hydrochloride (JP16/USP)
 |
| Other DBs |
CAS: 49745-95-1 PubChem: DrugBank: LigandBox: NIKKAJI: |
| KCF data |
 ATOM 23
1 C8y C 33.0803 -15.7788
2 C8x C 34.2973 -15.0858
3 C8x C 33.1444 -17.1820
4 C1b C 31.8691 -15.0800
5 C8y C 35.5083 -15.7904
6 C8x C 34.2856 -17.8866
7 C1b C 30.6522 -15.7788
8 C8y C 35.5026 -17.1879
9 O1a O 36.7252 -15.0974
10 N1b N 29.4411 -15.0858
11 O1a O 36.7136 -17.8923
12 C1c C 28.2359 -15.7845
13 C1b C 27.0189 -15.0858
14 C1a C 28.2359 -17.1820
15 C1b C 25.8079 -15.7845
16 C8y C 24.5909 -15.0858
17 C8x C 23.3856 -15.7845
18 C8x C 24.5909 -13.6883
19 C8x C 22.1687 -15.0858
20 C8x C 23.3856 -12.9839
21 C8y C 22.1687 -13.6883
22 O1a O 20.9518 -12.9839
23 X Cl 24.4937 -18.2392
BOND 23
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 5 8 2
8 5 9 1
9 7 10 1
10 8 11 1
11 10 12 1
12 12 13 1
13 12 14 1
14 13 15 1
15 15 16 1
16 16 17 2
17 16 18 1
18 17 19 1
19 18 20 2
20 19 21 2
21 21 22 1
22 6 8 1
23 20 21 1
|